• Foundation and Funding
  • International Affairs
  • PR and Marketing
  • Infrastructure
  • Biosamples and (Pre)clinic
  • Network
  • » 15.07.2015 3 Munich Biotech companies raise €100 mio in 5 days
    € 100 million capital increase in just 5 working days - what's going on in the Munich Biotech Cluster? » more
  • » 02.07.2015 Medigene AG secures over EUR 46mn from capital increase to finance its cancer immunotherapy programmes
    Medigene AG (MDG1, Frankfurt, Prime Standard) completed the capital increase announced on 12 June 2015 for the funding of its cancer immunotherapy programmes, achieving gross proceeds of approximately EUR 46.4 million by placing the maximum number of 5,594,178 new offered shares to existing shareholders and selected new institutional investors for... » more
  • » 17.06.2015 Munich´s SIRION Biotech Plans Opening of a New Office in the Boston Area
    SIRION Biotech, a leading viral vector platform company known for creating high quality viral vector solutions for industry and academic partners, today announced its commitment to open a new office in the vicinity of Boston. » more
  • » 15.06.2015 Meet Bavarian Biotech expertise at BIO USA in Philadelphia
    Bavaria welcomes you at the German Pavillion! » more
  • » 15.06.2015 1st online course @m4 eAcademy
    "Managing Innovation, Portfolios and Projects in the Life Sciences" starting July 1st » more
  • » 14.05.2015 US Juno Therapeutics acquires German Stage Cell Therapeutics in an $80M biotech buyout
    Subsidaries in Munich and Göttingen (both Germany) will be further operating. » more